Medtronic (MDT) Stock Price, News & Analysis

Company Overview

Medtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.

Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.

In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. 

Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. 

Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. 

Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.

Written by Jeffrey Neal Johnson

Key Stats

• Today's Range: $86.25 to $86.25
• 50-Day Range: $80.70 to $88.47
• 52-Week Range: $75.96 to $96.25
• Volume: 376,197 shs
• Average Volume: 7.70 million shs
• Market Capitalization: $110.16 billion
• P/E Ratio: 23.73
• Dividend Yield: 3.26%
• Price Target: $97.87
• Consensus Rating: Moderate Buy

Medtronic Stock Analysis - MarketRank™

Medtronic scored higher than 98% of companies evaluated by MarketBeat, and ranked 22nd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Medtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 8 buy ratings, 8 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Medtronic has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: 6.78%

Earnings Growth

Earnings for Medtronic are expected to grow by 6.78% in the coming year, from $5.46 to $5.83 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Medtronic is 23.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.71.

Price to Earnings Ratio vs. Sector

The P/E ratio of Medtronic is 23.76, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 25.73.

Price to Earnings Growth Ratio

Medtronic has a PEG Ratio of 2.33. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Medtronic has a P/B Ratio of 2.29. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.62% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently decreased by 42.19%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Medtronic pays a meaningful dividend of 3.24%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Medtronic has been increasing its dividend for 49 years.

Dividend Coverage

The dividend payout ratio of Medtronic is 77.35%. Payout ratios above 75% are not desirable because they may not be sustainable.

Dividend Sustainability

Based on earnings estimates, Medtronic will have a dividend payout ratio of 48.03% next year. This indicates that Medtronic will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -1.26

Percentage of Shares Shorted

0.62% of the float of Medtronic has been sold short.

Short Interest Ratio / Days to Cover

Medtronic has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Medtronic has recently decreased by 42.19%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 1.26

News Sentiment

Medtronic has a news sentiment score of 1.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 51 news articles for Medtronic this week, compared to 35 articles on an average week.

Search Interest

Only 42 people have searched for MDT on MarketBeat in the last 30 days. This is a decrease of -11% compared to the previous 30 days.

MarketBeat Follows

28 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is an increase of 8% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Medtronic insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.20% of the stock of Medtronic is held by insiders.

Percentage Held by Institutions

82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

MDT Stock Analysis - Frequently Asked Questions

How have MDT shares performed this year?

Medtronic's stock was trading at $79.88 at the beginning of 2025. Since then, MDT stock has increased by 7.7% and is now trading at $86.02.
View the best growth stocks for 2025 here.

How were Medtronic's earnings last quarter?

Medtronic PLC (NYSE:MDT) announced its quarterly earnings data on Wednesday, May, 21st. The medical technology company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.04. The firm's quarterly revenue was up 3.9% compared to the same quarter last year.
Read the conference call transcript.

Who are Medtronic's major shareholders?

Top institutional shareholders of Medtronic include Vanguard Group Inc. (9.75%), Massachusetts Financial Services Co. MA (1.74%), Bank of New York Mellon Corp (1.61%) and Deutsche Bank AG (1.48%). Insiders that own company stock include Geoffrey Martha, Sean Salmon, Gregory L Smith, Hoedt Rob Ten, Brett A Wall and Michael Marinaro.
View institutional ownership trends.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Medtronic investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Meta Platforms (META), NVIDIA (NVDA), Chevron (CVX), Verizon Communications (VZ) and Broadcom (AVGO).

Company Calendar

• Record date for 4/11 Dividend: 3/28/2025
• Ex-Dividend for 4/11 Dividend: 3/28/2025
• Dividend Payable: 4/11/2025
• Last Earnings: 5/21/2025
• Today: 6/23/2025
• Record date for 7/11 Dividend: 6/27/2025
• Ex-Dividend for 7/11 Dividend: 6/27/2025
• Dividend Payable: 7/11/2025
• Next Earnings (Estimated): 8/19/2025
• Fiscal Year End: 4/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NYSE:MDT
• CIK: 1613103
• Web: www.medtronic.com
• Phone: (531) 438-1700
• Fax: 763-514-4879
• Employees: 95,000
• Year Founded: 1949

Price Target and Rating

• Average Stock Price Target: $97.87
• High Stock Price Target: $110.00
• Low Stock Price Target: $87.00
• Potential Upside/Downside: +13.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 18 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $3.62
• Trailing P/E Ratio: 23.76
• Forward P/E Ratio: 15.75
• P/E Growth: 2.33
• Net Income: $4.66 billion
• Net Margins: 13.90%
• Pretax Margin: 16.78%
• Return on Equity: 14.54%
• Return on Assets: 7.83%

Debt

• Debt-to-Equity Ratio: 0.53
• Current Ratio: 1.85
• Quick Ratio: 1.42

Sales & Book Value

• Annual Sales: $33.54 billion
• Price / Sales: 3.29
• Cash Flow: $7.72 per share
• Price / Cash Flow: 11.14
• Book Value: $37.62 per share
• Price / Book: 2.29

Miscellaneous

• Outstanding Shares: 1,282,540,000
• Free Float: 1,279,978,000
• Market Cap: $110.32 billion
• Optionable: Optionable
• Beta: 0.79